Neurofibromatosis and MRI: Monitoring with Imaging

What is Neurofibromatosis (NF)? A Genetic Disorder Affecting the Body and Nervous System

Neurofibromatosis (NF) is a genetic disorder that affects the growth of nerve cells. It causes the formation of benign tumors (neurofibromas) in various parts of the body, particularly on the skin, brain, and spinal cord. While these tumors are generally non-cancerous, they can compress nerves and lead to pain, numbness, and other neurological problems. There are three main types of NF: NF1, which is the most common, and the rarer NF2 and Schwannomatosis. Each type has its own distinct symptoms and characteristics.

Symptoms and Disease Progression: Differences by NF Type

The most prominent symptom of NF1 is the presence of café-au-lait spots, which are light brown patches on the skin. Small tumors called neurofibromas also form under the skin. While usually harmless, they can become numerous. NF2 is characterized by tumors that form on the balance and hearing nerves (vestibular schwannomas), which can lead to hearing loss and balance issues. Schwannomatosis, unlike other types of NF, is primarily known for causing intense pain from the growth of schwannomas (nerve sheath tumors) in various parts of the body.

The Role of MRI in Diagnosis and Monitoring

While the diagnosis of Neurofibromatosis is often made through a physical exam and genetic testing, Magnetic Resonance Imaging (MRI) is a vital tool for monitoring tumors that may form in the brain and spinal cord. A cranial (brain) MRI and a spinal (spinal cord) MRI are used to determine the size, location, and number of these tumors. A contrast-enhanced MRI is particularly useful, as the contrast agent highlights the tumors, helping to differentiate them from other tissues and providing critical information for surgical planning. MRI scans are essential for tracking the disease’s progression and regularly checking the size of tumors, especially those on the hearing nerves.